Nissin reports on Japan’s first cultured steak meat with original flavor and texture
https://www.jst.go.jp/pr/announce/20220331/pdf/20220331.pdf
https://www.jst.go.jp/pr/announce/20220331/pdf/20220331.pdf
https://bio.nikkeibp.co.jp/atcl/news/p1/22/03/28/09321/
https://www.nedo.go.jp/news/press/AA5_101522.html
CureApp, a startup in Tokyo, is expected to obtain approval this April for its non-pharmacological digital therapy (DTx) of hypertension (rather: support of therapy). The medical device consists of two components: 1. an app to be used by the patient, and 2. an app for the physician to review the patient’s data. The patient enters […]
https://bio.nikkeibp.co.jp/atcl/news/p1/22/03/10/09248/
On March 9, 2022, the Ministry of Health, Labor, and Welfare approved CureApp’s HT hypertension control, the first software digital therapy (DTx) in Japan. Approval is expected for April 2022 and is The app is meant to assist in non-pharmacological therapy for patients with essential hypertension. It consists of two components: (1) an app for […]
https://bio.nikkeibp.co.jp/atcl/news/p1/22/03/10/09248/
https://bio.nikkeibp.co.jp/atcl/news/p1/22/03/02/09220/
On March 9, 2022, the Ministry of Health, Labor, and Welfare approved CureApp’s HT hypertension control, the first software digital therapy (DTx) in Japan. Approval is expected for April 2022 and is The app is meant to assist in non-pharmacological therapy for patients with essential hypertension. It consists of two components: (1) an app for […]